Better Clinical Data Management: Visual Analytics, Real-Time Insights, Traceable Decisions, Oh My!

Effective clinical data management is the foundation for a successful clinical trial.  

For clinical data managers (CDMs) operating in today’s clinical environment, this responsibility is complex. Tasked with collecting, cleaning, and managing clinical data in compliance with regulatory standards, CDMs design databases, manage data processing, generate queries, create data management plans, oversee quality monitoring and reporting, and interface with multidisciplinary teams.  

Today’s clinical trials involve multiple data sources and globally dispersed clinical sites, presenting significant challenges for CDMs, with many taking a reactive, rather than proactive, approach to clinical data management.  

In this blog, we’ll dive deeper into these challenges and provide a solution for streamlined data review and more effective communication. 


The Many Challenges in Clinical Data Management 

Clinical trials have become increasingly complex over the last decade.  

Here’s how:

  • There’s more data: According to a 2021 report from the Tufts Center for the Study of Drug Development, Phase III clinical trials generate 3.6 million data points (on average), a 3-fold increase compared to 2011.  
  • There are more data sources: An increasing number of data streams, such as those from digital health technologies, exist beyond electronic case report forms and are often managed outside traditional electronic data capture (EDC) systems.

To manage this deluge of data and its diverse sources, many CDMs continue to rely on spreadsheets, manual data alignment/cross-checking, and siloed systems. This creates a considerable burden for CDMs, and an industry survey found that 55% of them list data integration and reconciliation from various sources as a significant pain point.  

Traditional spreadsheet-heavy review processes are not only time-consuming but also prone to human error. Cycle times lengthen as data managers struggle to reconcile discrepancies across systems. Meanwhile, regulators like the FDA are pushing for greater transparency and timely issue resolution, emphasizing real-time data oversight and traceable decision-making in their guidance.

These reactive methods don’t meet the needs of today’s CDMs managing today’s clinical trials. 


The Solution: Real-Time Visual Analytics

Visual analytics platforms address these challenges, moving beyond static and fragmented data sources. Peer-reviewed studies confirm that implementing visual analytics, particularly through dashboards and centralized, risk-based monitoring, enables the earlier and more efficient identification of critical issues compared to traditional batch review processes. For instance, unsupervised anomaly detection methods have been shown to reduce manual review workload by approximately 3.5 times, enabling CDMs to focus on the most actionable data concerns in near real-time.
 

Here’s what makes them transformative:
 

Immediate Insights Across All Data Sources

Integrated dashboards consolidate information from EDC systems, labs, and patient-reported outcomes. This eliminates data silos and manual reconciliations, giving CDMs a single source of truth. 


Early Detection of Critical Issues

As referenced above, by visualizing trends, patterns, and outliers in real time, CDMs can identify anomalies earlier than with traditional methods. This proactive monitoring reduces the risk of downstream delays.


Traceability for Regulatory Compliance 

The FDA emphasizes the importance of data oversight and traceability in clinical data. In compliance with their guidance, analytics platforms provide built-in audit trails that record every review decision, creating a transparent and inspection-ready environment.  


Enhanced Collaboration

Role-based access and shared dashboards allow CDMs, monitors, and medical reviewers to align quickly. Automated alerts prioritize high-risk data, so the right people act at the right time.

Taken together, visual analytics drives faster query resolution, fewer delays, and higher-quality data for shorter timelines and reduced operational costs, delivering tangible value.

 

Signals Clinical Connect

Join us!

for our Signals Clinical Connect webinar series and learn how to revolutionize your clinical data review, medical review analytics, and workflows.

Signals Clinical: Streamline Data Review and Communication 

CDMs aren’t data custodians any longer; they are data strategists who can enable trial success with real-time analytics and proactive approaches to clinical trial data management.

Revvity Signals and developed an end-to-end clinical data management solution, Signals Clinical™, a secure, scalable platform that enhances study data quality, patient safety, and operational oversight by combining real-time data access, robust analytics, and traceable decision-making. We make data visualization and customization easy with pre-built analytics dashboards with the flexibility to generate study- and therapeutic-specific visuals using SpotfireⓇ. This empowers CDMs and medical monitors to generate rapid insights that directly support data quality and patient safety throughout a study.

 

The benefits of Signals Clinical include:

  • Traceable Decisions: Capture and document clinical decisions within your visualizations and workflows so that your data is unified and inspection-ready.
  • Secure Data: We take a “Security by Design” approach, safeguarding sensitive patient information through advanced encryption, access controls, and compliance with industry best practices.
  • Lower Costs: Repeatable tasks can be automated, data mapping streamlined, and designs reused to maximize productivity and reduce operational costs.
  • Easy Integration and Data Access: Signals Clinical integrates seamlessly with major EDC systems, such as Medidata Rave EDC and Veeva EDC, as well as other sources, ensuring accuracy and accessibility for analysis.
  • Rapid and Scalable Deployment: Adapt to changing data volumes and resource requirements, ensuring agility across complex and fast-paced studies. 

Ready to be proactive about clinical data management? See Signals Clinical in action.

node:field_display_author:entity:field_person_image:entity:image:alt
Christie Quarles
Senior Clinical Product Marketing Manager

Christie is a Senior Clinical Product Marketing Manager at Revvity Signals. She brings over 20 years of leadership in life sciences and clinical analytics to her role. As a seasoned product leader with deep experience in clinical trials, real‑world evidence, vaccine commercialization, and genomics, she has successfully shaped go‑to‑market strategies for global SaaS solutions in biotechnology and healthcare.